Get the Stockscreener App
59.02
2.28%
-1.38
Pre-market:
57.41
-1.61
-2.73%
Procept Biorobotics Corp stock is traded at $59.02, with a volume of 771.51K.
It is down -2.28% in the last 24 hours and up +1.64% over the past month.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
See More
Previous Close:
$60.40
Open:
$59.39
24h Volume:
771.51K
Relative Volume:
0.79
Market Cap:
$3.55B
Revenue:
$249.12M
Net Income/Loss:
$-90.19M
P/E Ratio:
-34.72
EPS:
-1.7
Net Cash Flow:
$-88.21M
1W Performance:
-8.11%
1M Performance:
+1.64%
6M Performance:
-33.36%
1Y Performance:
-4.87%
1-Day Range:
$58.34
$60.87
1-Week Range:
$58.34
$64.70
52-Week Range:
$47.04
$103.81
Procept Biorobotics Corp Stock (PRCT) Company Profile
Name
Procept Biorobotics Corp
Sector
Industry
Phone
(650) 232-9832
Address
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
59.02 | 3.55B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
132.28 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
SYK
Stryker Corp
|
373.37 | 147.15B | 23.22B | 2.86B | 3.58B | 7.40 |
|
BSX
Boston Scientific Corp
|
101.73 | 146.97B | 17.55B | 2.03B | 2.72B | 1.37 |
|
MDT
Medtronic Plc
|
86.17 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
73.27 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Initiated | Jefferies | Hold |
| Aug-11-23 | Initiated | Piper Sandler | Overweight |
| May-31-23 | Initiated | William Blair | Outperform |
| Oct-31-22 | Initiated | BTIG Research | Neutral |
| Oct-25-22 | Initiated | Truist | Buy |
| Sep-02-22 | Initiated | Wells Fargo | Overweight |
| Jul-15-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Goldman | Neutral |
| Oct-11-21 | Initiated | Guggenheim | Buy |
| Oct-11-21 | Initiated | SVB Leerink | Outperform |
View All
Procept Biorobotics Corp Stock (PRCT) Latest News
Procept BioRobotics at 2025 Truist Conference: Strategic Growth Path - Investing.com
Rhumbline Advisers Buys 3,077 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
Robotics Stocks To ResearchJune 5th - MarketBeat
PROCEPT BioRobotics Corp (PRCT) Shares Up 6.15% on Jun 5 - GuruFocus
Procept Biorobotics at Jefferies Conference: Strategic Innovations in BPH Treatment - Investing.com
Procept BioRobotics at 45th Annual William Blair Growth Stock Conference: Aquablation Advances - Investing.com
PROCEPT BioRobotics Corp (PRCT) Shares Up 5.85% on Jun 3 - GuruFocus
PROCEPT BioRobotics Corp (PRCT) Stock Price Up 3.89% on May 30 - GuruFocus
PROCEPT BioRobotics Corp (PRCT) Stock Price Down 3.29% on May 29 - GuruFocus
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Shares Sold by Ameriprise Financial Inc. - Defense World
Robotics Stocks To Follow TodayMay 18th - MarketBeat
PROCEPT BioRobotics Stock Takes a Breather. Is It a Buy? - Nanalyze
Procept BioRobotics at Bank of America Conference: Strategic Growth Insights - Investing.com
Stock Performance Spotlight: Procept BioRobotics Corp (PRCT) Ends the Day at 53.11, Down by -0.23 - DWinneX
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Procept BioRobotics Corp (PRCT) expanding its growth trajectory ahead - Sete News
Ready to Jump After Recent Trade: Incyte Corp (INCY) - Sete News
Leerink Partnrs Has Negative Outlook of PRCT Q2 Earnings - Defense World
Market Insight: Procept BioRobotics Corp (PRCT)’s Notable Drop, Closing at 53.98 - DWinneX
William Blair Issues Pessimistic Forecast for PRCT Earnings - Defense World
Did Procept BioRobotics Corp (PRCT) perform well in the last session? - uspostnews.com
Mariner LLC Purchases 2,429 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT) - Defense World
PROCEPT BioRobotics Leadership to Present at Four Premier Healthcare Investment Conferences - Stock Titan
Leerink cuts Procept BioRobotics price target to $90, keeps outperform By Investing.com - Investing.com Nigeria
Promising Potential of PROCEPT BioRobotics’ Aquablation Technology in Prostate Cancer Treatment Drives Buy Rating - TipRanks
Leerink cuts Procept BioRobotics price target to $90, keeps outperform - Investing.com
Bank of America Cuts PROCEPT BioRobotics (NASDAQ:PRCT) Price Target to $84.00 - Defense World
Procept BioRobotics Corp [PRCT] Records 50-Day SMA of $58.96 - knoxdaily.com
Procept BioRobotics price target lowered to $84 from $104 at BofA - TipRanks
Closing Figures: Procept BioRobotics Corp (PRCT)’s Negative Finish at 52.56, Down -5.64 - DWinneX
Procept BioRobotics Corp [PRCT] stock Initiated by Morgan Stanley analyst, price target now $105 - dbtnews.com
Where PROCEPT BioRobotics Stands With Analysts - Benzinga
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q1 2025 Earnings Call Transcript - Insider Monkey
Procept BioRobotics (PRCT) Target Price Cut to $84 by BofA Analy - GuruFocus
Procept BioRobotics reports Q1 EPS (45c), consensus (49c) - TipRanks
PROCEPT BioRobotics (NASDAQ:PRCT) Sees Large Volume Increase on Earnings Beat - Defense World
PROCEPT BioRobotics Sees Strong Revenue Growth in Q1 2025 - TipRanks
Earnings call transcript: Procept Biorobotics beats Q1 2025 EPS forecast By Investing.com - Investing.com India
Procept Biorobotics Corp. Reports Strong Q1 Growth Amid Challenges - TipRanks
Procept BioRobotics sees FY25 revenue $323M, consensus $321.67M - TipRanks
Breakthrough BPH Treatment: Experts Reveal Long-Term Aquablation Results at Major Urology Conference - Stock Titan
Morgan Stanley lowers Procept BioRobotics price target, sees buying opportunity - TipRanks
Procept BioRobotics Corp’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - investchronicle.com
PROCEPT BioRobotics (PRCT) Sees Significant Revenue Growth in Q1 2025 - GuruFocus
Procept BioRobotics Corp (NASDAQ:PRCT): It’s all about numbers this morning - uspostnews.com
Nothing is Better Than Procept BioRobotics Corp (PRCT) stock at the moment - Sete News
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates - MSN
Earnings call transcript: Procept Biorobotics beats Q1 2025 EPS forecast - Investing.com
Procept Biorobotics earnings beat by $0.04, revenue topped estimates - Investing.com
Why Procept Biorobotics Shares Are Under Pressure - TipRanks
PROCEPT BioRobotics Reports First Quarter 2025 Financial Results - TradingView
Procept Biorobotics Corp Stock (PRCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):